Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - TherapeuticsMD, Inc. | d10q.htm |
| EX-31.1 - SECTION 302 PEO AND PFO CERTIFICATION - TherapeuticsMD, Inc. | dex311.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of AMHN, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2010 as filed with the Securities and Exchange Commission on November 5, 2010 (the “Report”), I, Robert Cambridge, Principal Executive Officer and Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| /s/ Robert Cambridge |
| Robert Cambridge |
| Principal Executive Officer |
| Principal Financial Officer |
| November 5, 2010 |
A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
35